指南与共识脑血管病

参与「遵循指南-卒中」项目与卒中医疗质量的相关性

Participation in Get With The Guidelines-Stroke and Its Association With Quality of Care for Stroke.
指南 / 共识 · JAMA Neurol · 2018-01-01

本研究基于REGARDS队列中546例缺血性卒中患者,比较参与与未参与「遵循指南-卒中」项目的医院在10项循证干预上的医疗质量。参与医院患者更可能接受其中5项干预,平均接受干预数5.4 vs 4.8(P<.001),数据独立于该项目收集,记录参与医院卒中医疗改善。

要点

  • 参与GWTG-Stroke医院的患者更可能接受组织型纤溶酶原激活剂(RR 3.74)、危险因素教育(RR 1.54)、吞咽评估(RR 1.25)、血脂评估(RR 1.18)和神经科医生评估(RR 1.12)。
  • 参与医院患者平均接受5.4项(95%CI 5.2-5.6)干预,未参与医院为4.8项(95%CI 4.6-5.0),P<.001。
  • 数据独立于GWTG-Stroke项目收集,记录参与医院缺血性卒中患者医疗改善。

核心结论

  • 独立于GWTG-Stroke项目收集的数据显示,参与医院收治的缺血性卒中患者医疗质量改善。

研究设计与样本

  • REGARDS研究(基于人群的队列,2003至2007年招募30239名45岁及以上随机选择的黑人和白人参与者)9年随访期间发生缺血性卒中的546名参与者的亚组分析,其中207例(36%)在参与GWTG-Stroke的医院治疗,339例在未参与医院治疗,数据分析时间为2017年7月29日至2018年4月17日。

主要发现

  • 参与医院患者平均(SD)年龄74(8)岁,207例中100例为男性(48%);未参与医院患者平均(SD)年龄73(9)岁,339例中161例为男性(48%)。
  • 参与医院患者更可能接受10项循证干预中的5项:组织型纤溶酶原激活剂(RR 3.74;95%CI 1.65-8.50)、危险因素教育(RR 1.54;95%CI 1.16-2.05)、吞咽评估(RR 1.25;95%CI 1.04-1.50)、血脂评估(RR 1.18;95%CI 1.05-1.32)、神经科医生评估(RR 1.12;95%CI 1.05-1.20)。
  • 参与医院患者平均接受5.4项(95%CI 5.2-5.6)干预,未参与医院为4.8项(95%CI 4.6-5.0),P<.001。

关键数值与推荐

  • 质量医疗措施包括组织型纤溶酶原激活剂使用、吞咽评估、48小时内抗血栓药物使用、血脂谱评估、出院抗血栓治疗、出院他汀类药物、神经科医生评估、提供减重和运动咨询、卒中危险因素和预警症状教育以及康复评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Get With The Guidelines-Stroke (GWTG-Stroke) is an American Heart Association/American Stroke Association stroke-care quality-improvement program; however, to our knowledge, there has not been a direct comparison of the quality of care between patients hospitalized at participating hospitals and those at nonparticipating hospitals. OBJECTIVE: To contrast quality of stroke care measures for patients admitted to hospitals participating and not participating in GWTG-Stroke. DESIGN, SETTING, AND PARTICIPANTS: Subpopulation of 546 participants with ischemic stroke occurring during a 9-year follow-up of the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study, a population-based cohort study of 30 239 randomly selected black and white participants 45 years and older recruited between 2003 and 2007. Of those with stroke, 207 (36%) were treated in a hospital participating in GWTG-Stroke and 339 in a nonparticipating hospital. Data were analyzed between July 29, 2017, and April 17, 2018. MAIN OUTCOMES AND MEASURES: Quality of care measures including use of tissue plasminogen activator, performance of swallowing evaluation, antithrombotic use in first 48 hours, lipid profile assessment, discharge receiving antithrombotic therapy, discharge receiving a statin, neurologist evaluation, providing weight loss and exercise counseling, education on stroke risk factors and warning signs, and assessment for rehabilitation. RESULTS: Participants treated at participating hospitals had a mean (SD) age of 74 (8) years and 100 of 207 were men (48%), while those seen at nonparticipating hospitals had a mean (SD) age of 73 (9) years, and 161 of 339 were men (48%). Those seen in participating hospitals were more likely to receive 5 of 10 evidence-based interventions recommended for patients hospitalized with ischemic stroke, including receiving tissue plasminogen activator (RR, 3.74; 95% CI, 1.65-8.50), education on risk factors (RR, 1.54; 95% CI, 1.16-2.05), having an evaluation for swallowing (RR, 1.25; 95% CI, 1.04-1.50), a lipid evaluation (RR, 1.18; 95% CI, 1.05-1.32), and an evaluation by a neurologist (RR, 1.12; 95% CI, 1.05-1.20). Those seen in participating hospitals received a mean of 5.4 (95% CI, 5.2-5.6) interventions compared with 4.8 (95% CI, 4.6-5.0) in nonparticipating hospitals (P < .001). CONCLUSIONS AND RELEVANCE: These data collected independently of the GWTG-Stroke program document improved stroke care for patients with ischemic stroke hospitalized at participating hospitals.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Howard G, Schwamm LH, Donnelly JP, et al. Participation in Get With The Guidelines-Stroke and Its Association With Quality of Care for Stroke. JAMA Neurol. 2018. PMID: 30083763. doi:10.1001/jamaneurol.2018.2101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。